BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35041720)

  • 1. Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).
    Zarei Ghobadi M; Emamzadeh R
    PLoS One; 2022; 17(1):e0262739. PubMed ID: 35041720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study.
    Zarei Ghobadi M; Emamzadeh R; Teymoori-Rad M; Mozhgani SH
    Virol J; 2021 Aug; 18(1):175. PubMed ID: 34446027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
    Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
    Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
    Tarokhian H; Rahimi H; Mosavat A; Shirdel A; Rafatpanah H; Akbarin MM; Bari A; Ramezani S; Rezaee SA
    BMC Cancer; 2018 Dec; 18(1):1287. PubMed ID: 30577817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-lymphotropic virus 1 (HTLV-1) pathogenesis: A systems virology study.
    Mozhgani SH; Zarei-Ghobadi M; Teymoori-Rad M; Mokhtari-Azad T; Mirzaie M; Sheikhi M; Jazayeri SM; Shahbahrami R; Ghourchian H; Jafari M; Rezaee SA; Norouzi M
    J Cell Biochem; 2018 May; 119(5):3968-3979. PubMed ID: 29227540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).
    Zarei-Ghobadi M; Sheikhi M; Teymoori-Rad M; Yaslianifard S; Norouzi M; Yaslianifard S; Faraji R; Farahmand M; Bayat S; Jafari M; Mozhgani SH
    BMC Res Notes; 2021 Mar; 14(1):109. PubMed ID: 33757561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
    Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
    J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1.
    de Sena Rodrigues Júnior R; Antonia Nunes Gomes J; Alberto da Silva Dias G; Fujihara S; Toshimitsu Yoshikawa G; Vilela Lopes Koyama R; Catarina Medeiros Sousa R; Antonio Simões Quaresma J; Thais Fuzii H
    Immunobiology; 2023 Nov; 228(6):152740. PubMed ID: 37657359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
    Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
    J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals.
    Letafati A; Mozhgani SH; Marjani A; Amiri A; Siami Z; Mohammaditabar M; Molaverdi G; Hedayatyaghoobi M
    Med Oncol; 2023 Oct; 40(11):317. PubMed ID: 37792095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL).
    Ahmadi Ghezeldasht S; Blackbourn DJ; Mosavat A; Rezaee SA
    Crit Rev Clin Lab Sci; 2023 May; 60(3):189-211. PubMed ID: 36593730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis.
    Zarei Ghobadi M; Mozhgani SH; Erfani Y
    J Neurovirol; 2021 Dec; 27(6):820-830. PubMed ID: 33405203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin-like adult T-cell leukemia/lymphoma that developed during the follow-up of HTLV-1 associated myelopathy/tropical spastic paraparesis.
    Nakaya Y; Yoshida M; Tsutsumi M; Fuseya H; Horiuchi M; Yoshimura T; Hayashi Y; Nakao T; Koh KR; Niino D; Inoue T; Yamane T
    J Clin Exp Hematop; 2019 Sep; 59(3):130-134. PubMed ID: 31391405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
    Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
    AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Rajaei T; Farajifard H; Rafatpanah H; Bustani R; Valizadeh N; Rajaei B; Rezaee SA
    Med Microbiol Immunol; 2017 Jun; 206(3):195-201. PubMed ID: 28378248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.